Sahm Adrangi, who is perhaps best known for his work with Karrisdale Capital and for his extensive work in and writing on short selling, is a American hedge fund manager and businessman. Sahm Adrangi first came to broader public attention after he short sold and then exposed a series of underhanded Chinese companies such as Chinese Marine Food Group, China Biotics and Lihua International back in 2010 through 2011. After his successes, both ethically and financially, Sahm Adrangi redirected his attention on a wide variety of those financial fields such as biotech, mining, therapeutics and company creation as well as start up investments, and his Facebook.

Sahm Adrangi is a graduate of Yale University from which he earned a bachelor of arts in economics. Mr. Adrangi is also a prolific speaker who is a common sight at numerous conferences such as well known gatherings like the Traders 4 A Cause, Activist Investor Conference, the Distressed Debt Investing Conference and Sohn Conference. In addition to all of this, Mr. Adrangi has also appeared on numerous mainstream media outlets such as the business coverage channels Bloomberg and the Wall Street Journal as well as the current affairs channel CNBC and the New York Times, Washington Post and Business Week, and http://fortune.com/2016/04/21/sahm-adrangi-kerrisdale-short-sale/.

Most recently, Mr. Adrangi has received a great deal of media coverage for calling a series of biotech disasters in advance. The primary piece of prognostication which was picked up by sites like Endpoints News, concerned Adrangi stating the Bavarian Nordic, a biotech firm located in Denmark, would fail at successfully developing a cancer vaccine. The hedge fund manager’s call turned out to be correct as Bavarian Nordic’s vaccine flopped. This occurred around the same period of time Adrangi was also covering and making predictions on numerous other similar companies such as Sage Therapeutics and Prothena, and Twitter.com.